Historical record - last NADAC publication: 8/17/2022
Strength
15; 92 mg/1; mg/1
Manufacturer
Vivus LLCNDC
62541020430
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
8/17/2022
Active Ingredients
PHENTERMINE HYDROCHLORIDE; TOPIRAMATEApproval Type
New Drug (NDA)
FDA Application
NDA022580On Market Since
9/17/2012
Pharmacological Classes
Price Statistics
The NADAC for QSYMIA 15 MG-92 MG CAPSULE has been published 454 times since Apr 23, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3680 per EA |
|---|---|
| All-time high | $6.5825 (Mar 11, 2015) |
| All-time low | $6.3442 (Apr 17, 2019) |
| Median price | $6.4033 |
| Average price | $6.4092 |
| Largest weekly change | +2.8% (Oct 22, 2014) |
| Weeks tracked | 454 |
| Tracking since | Apr 23, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 46% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QSYMIA 15 MG-92 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for QSYMIA 15 MG-92 MG CAPSULE, manufactured by Vivus LLC, is $6.3680 per EA (NDC 62541020430), effective Dec 28, 2022.
How has the price of QSYMIA 15 MG-92 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for QSYMIA 15 MG-92 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 454 weekly CMS publications since Apr 23, 2014.
What are the highest and lowest recorded NADAC prices for QSYMIA 15 MG-92 MG CAPSULE?
Since Apr 23, 2014, the NADAC for QSYMIA 15 MG-92 MG CAPSULE has ranged from a low of $6.3442 (Apr 17, 2019) to a high of $6.5825 (Mar 11, 2015), with a median of $6.4033 per EA.
Are there cheaper alternatives to QSYMIA 15 MG-92 MG CAPSULE?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE, is $3.4119 per EA — about 46% below QSYMIA 15 MG-92 MG CAPSULE.
Who manufactures QSYMIA 15 MG-92 MG CAPSULE?
QSYMIA 15 MG-92 MG CAPSULE (NDC 62541020430) is labeled by Vivus LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification